Copy

 

Daily Recap

Medical schools are starting to diversify. But they’re learning hard lessons along the way

By Leah Samuel

Molly Ferguson for STAT

After schools were threatened with losing their accreditation if they didn't diversify, many made progress — and learned it's about more than numbers.

Read More

Inhumane or unavoidable? As Congress scrutinizes an increase in monkey research, scientists defend its necessity

By Ruth Hailu

JEAN-FRANCOIS MONIER/AFP/Getty Images

Scientists are relying on monkey research more than ever before. Congress wants the NIH and FDA to explain why that research is so important.

Read More

Opinion: Ghost networks of psychiatrists make money for insurance companies but hinder patients’ access to care

By Jack Turban

Alex Hogan/STAT, Adobe

Insurers' out-of-date or fraudulent lists of mental health providers — ghost networks — can prevent vulnerable individuals from getting the care they need.

Read More

Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry

By Matthew Herper

Ruby Wallau for STAT

Targeted cancer drugs such as the ones that Array develops have been a major part of Pfizer’s research over the past decade.

Read More

STAT Plus: CRISPR lab begs the question: Where is the line between industry and academia?

By Matthew Herper

Akira Suemori/AP

Figuring out exactly where the lines should be between an academic scientist and an industry one is a constant negotiation.

Read More

Monday, June 17, 2019

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2019, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>